|
T38287 |
C3a Receptor Agonist
|
C3a receptor agonist 1,Complement 3a Receptor Agonist |
Complement System
|
|
C3a Receptor Agonist (C3a receptor agonist 1) binds the G protein-coupled C3a receptors (C3aRs) in the immune system complement pathway. Activation of C3aR prevents neutrophils from being mobilized in a model of intestin... |
|
T7497L |
C3a 70-77 2TFA(63555-63-5(free base))
|
Complement 3a (70-77) |
Complement System
|
|
C3a 70-77 2TFA(63555-63-5(free base)) (Complement 3a (70-77)) is an octapeptide corresponding to the COOH terminus of C3a. |
|
T7497 |
C3a (70-77)
|
Complement 3a (70-77),C3a 70-77 |
Complement System
|
|
C3a (70-77) is an octapeptide corresponding to the COOH terminus of C3a. |
|
TP1193 |
C3a (70-77) TFA (63555-63-5 free base)
|
C3a (70-77) TFA,Complement 3a (70-77) (TFA) |
|
|
C3a (70-77) TFA (Complement 3a (70-77) TFA) is a COOH-terminal fragment of the C3a anaphylatoxin peptide. |
|
TP2296L |
TLQP 21 acetate
|
|
Complement System
|
|
TLQP 21 acetate is a potent agonist of G-protein-coupled receptor complement-3a receptor 1 (C3aR1). The EC50 values are 10.3 μM for mouse and 68.8 μM for human. TLQP 21 acetate is a VGF-derived peptide with endocrine a... |
|
T75966 |
C3a (70-77) (TFA)
|
|
|
|
Complement 3a (70-77) TFA is an octapeptide that corresponds to the COOH terminus of C3a and exhibits the specificity and 1 to 2% biological activities of C3a [1] [2]. |
|
T38077 |
TLQP-21 TFA
|
|
|
|
TLQP-21 TFA, a VGF-derived peptide endowed of endocrine and extraendocrine properties, is a potent G-protein-coupled receptor complement-3a receptor1 (C3aR1) agonist (EC50: mouse TLQP-21=10.3 μM; human TLQP-21=68.8μM). T... |
